📍 Koramangala, Bengaluru — 560 034
Home About Services Technology For Patients For Clinicians Our Team FAQ Contact
Ion Torrent NGS Platform  ·  Est. 2015

Where Genetics Meets the Promise of Parenthood

South India's most experienced reproductive genetics laboratory — a decade of expertise, 5000+ embryos tested, and a full spectrum of cytogenetic and molecular genetic services.

5000+
PGT-A Embryos Tested
10
Years of Expertise
7+
Genetic Tests Offered
Flagship Service

PGT-A via Ion Torrent NGS — whole-chromosome copy number analysis for all 24 chromosomes, every embryo

Scientific Leadership

Led by Dr. Jayaram and Dr. Swathi — specialist geneticists with deep expertise in reproductive and clinical genetics

Comprehensive Services

PGT-A · PGT-M · PGT-SR · NIPT · Karyotyping · FISH · HLA Typing — all under one roof in Bangalore

Fast Turnaround

Rapid reporting designed around your IVF cycle windows — fresh and frozen transfer timelines respected

🧪 Ion Torrent NGS Platform
🎓 Expert Scientific Directors
📊 5000+ PGT-A Cases
📅 Est. 2015 · 10 Years
📍 Koramangala, Bengaluru
Fast TAT for IVF Cycles
For Patients

Your path to a healthy baby starts here

Genetic testing sounds complex — we make it simple, compassionate, and clear. Whether you are beginning IVF or have had recurrent losses, our team will guide you every step of the way.

  • Why embryo testing matters for your IVF success
  • What to expect: how samples are collected and tested
  • Understanding your genetic report in plain language
  • How PGT-A, NIPT and other tests protect your baby's health
  • Genetic counselling support before and after testing
Patient Guide →
For Clinicians

Precision genetics for your IVF practice

We are your dedicated genetics partner — rigorous NGS methodology, deep clinical integration, and a scientific team that speaks your language.

  • PGT-A, PGT-M, PGT-SR with NGS on Ion Torrent platform
  • Clinical consultation on complex chromosomal rearrangements
  • Streamlined referral, biopsy coordination and reporting
  • Detailed aneuploidy and mosaicism interpretation
  • Turnaround optimised for fresh and frozen transfer cycles
Clinician Resources →
5000+
PGT-A Embryos Analysed
10 yrs
Clinical Experience
24
Chromosomes Screened
>99%
NIPT Detection Rate
Fast
TAT for IVF Cycles
Our Services

Comprehensive Reproductive Genetic Testing

A full suite of cytogenetic and molecular genetic tests — preimplantation, prenatal, and postnatal.

01 · PREIMPLANTATION

PGT-A — Aneuploidy Screening

NGS-based screening of all 24 chromosomes in IVF embryos to identify euploid embryos for transfer.

PatientsClinicians
02 · PREIMPLANTATION

PGT-M — Monogenic Disorders

For couples carrying known single-gene mutations — Beta-Thalassemia, DMD, OI, Glycogen Storage Disorders, and more.

PatientsClinicians
03 · PREIMPLANTATION

PGT-SR — Structural Rearrangements

For couples with balanced chromosomal translocations or inversions to prevent miscarriage and affected offspring.

PatientsClinicians
04 · PRENATAL

NIPT — Non-Invasive Prenatal Screening

A simple blood draw detecting Trisomy 21, 18, 13 and sex chromosome aneuploidies with >99% accuracy.

PatientsClinicians
05 · CYTOGENETICS

Karyotyping & FISH

Standard chromosome analysis and targeted fluorescence probes for infertility workup and prenatal diagnosis.

PatientsClinicians
06 · IMMUNOGENETICS

HLA Typing

Human Leucocyte Antigen typing for recurrent implantation failure, RPL, and saviour sibling programmes.

PatientsClinicians
View All Services in Detail →
About Tattvagene

A decade of reproductive genetics excellence

2015
Founded
5000+
PGT-A Cases
7+
Test Categories
NGS
Ion Torrent

"Our mission: reliable genetic testing using the most advanced technology, to help every couple achieve a healthy pregnancy."

Founded in 2015, Tattvagene was built with a singular focus — to bring the precision of cutting-edge reproductive genetics directly into the IVF workflow. Over the past decade, we have grown into one of India's most experienced reproductive genetics centres, having performed over 5000 PGT-A analyses.

Our laboratory is equipped with Next Generation Sequencing (NGS) on the Thermo Fisher Ion Torrent platform, delivering whole-chromosome copy number analysis across all 24 chromosomes with high sensitivity for mosaicism detection.

From standard PGT-A through complex monogenic disorder testing for conditions like Beta-Thalassemia, Duchenne Muscular Dystrophy, and Osteogenesis Imperfecta, we offer a comprehensive genetic testing suite. We welcome referrals from all IVF centres and fertility specialists across India.

📍 Location

#365, Sulochana Building, 1st Cross Road, 3rd Block, Sarjapur Main Road, Koramangala, Bengaluru — 560 034

🧪 Platform

Thermo Fisher Ion Torrent semiconductor NGS — rapid, accurate, whole-chromosome copy number profiling

What Sets Us Apart

Why choose Tattvagene

🏆

10 Years of Experience

One of India's longest-running dedicated reproductive genetics laboratories — over 5000 PGT-A cases performed with consistent quality.

🔬

Ion Torrent NGS Technology

Semiconductor sequencing delivers high-resolution chromosomal analysis including mosaicism detection that microarrays cannot match.

Fast Turnaround Times

Our TAT is designed to fit your freeze-all and frozen transfer protocols without delays — because every day matters in an IVF cycle.

🤝

Open Referral Policy

We welcome referrals from all IVF clinics and fertility specialists regardless of affiliation. Every patient deserves access to excellent genetics.

💬

Clinical Support

Our scientific directors are available for pre-test consultation and post-report discussion on complex PGT-M and mosaic embryo cases.

🧰

Complete Test Menu

PGT-A, PGT-M, PGT-SR, NIPT, Karyotyping, FISH, HLA Typing — one laboratory for your full reproductive genetics needs.

Our Services

Comprehensive Reproductive Genetic Testing

From embryo screening to prenatal diagnosis — a complete suite of cytogenetic and molecular genetic tests, all under one roof.

01 · PREIMPLANTATION GENETICS

PGT-A — Preimplantation Genetic Testing for Aneuploidies

NGS-based screening of all 24 chromosomes in IVF embryos to identify euploid embryos for transfer. Reduces implantation failure and miscarriage rates, and improves live birth rates — particularly in advanced maternal age, recurrent implantation failure, and recurrent pregnancy loss. We use the Ion Torrent platform for quantitative copy number analysis including mosaicism detection and reporting per current PGDIS/ESHRE guidelines.

PatientsClinicians
02 · PREIMPLANTATION GENETICS

PGT-M — Preimplantation Genetic Testing for Monogenic Disorders

For couples carrying known single-gene mutations. We test embryos for the specific familial variant so only unaffected embryos are transferred. Conditions we have managed include Beta-Thalassemia, Duchenne Muscular Dystrophy, Osteogenesis Imperfecta, and Glycogen Storage Disorders. Saviour sibling programmes combining PGT-M with HLA matching are available. Pre-test workup (4–8 weeks) is required for each new condition.

PatientsClinicians
03 · PREIMPLANTATION GENETICS

PGT-SR — Preimplantation Genetic Testing for Structural Rearrangements

For couples with balanced chromosomal translocations (reciprocal and Robertsonian) or inversions. These couples risk generating embryos with unbalanced chromosomal material, leading to miscarriage or chromosomally affected offspring. PGT-SR uses NGS-based copy number analysis to identify chromosomally balanced embryos suitable for transfer, significantly improving live birth outcomes.

PatientsClinicians
04 · PRENATAL SCREENING

NIPT / NIPS — Non-Invasive Prenatal Screening

A simple maternal blood draw from 10 weeks gestation. Cell-free fetal DNA analysis screens for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and sex chromosome aneuploidies with a detection rate exceeding 99%. Safe, accurate, and carries no risk to the pregnancy. Suitable for singleton and twin pregnancies including IVF conceptions.

PatientsClinicians
05 · CYTOGENETICS

Chromosome Analysis (Karyotyping)

Standard G-banding karyotype analysis for couples with infertility, recurrent miscarriage, or a family history of chromosomal disorders. Detects numerical and structural chromosome abnormalities. Essential pre-ART workup for both partners. Available for prenatal samples (amniocyte/CVS) and postnatal blood samples. Results inform assisted conception planning and genetic counselling.

PatientsClinicians
06 · CYTOGENETICS

FISH — Fluorescence In Situ Hybridisation

Targeted detection of chromosomal abnormalities using fluorescent DNA probes. Applications include microdeletion syndromes (Prader-Willi/Angelman), sex chromosome verification (SRY), sperm FISH for males with severe oligospermia or azoospermia, and rapid aneuploidy screening in prenatal samples. Complements karyotyping where higher resolution is needed for specific loci.

PatientsClinicians
07 · IMMUNOGENETICS

HLA Typing — Human Leucocyte Antigen

HLA typing for recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL) investigation. Couples with excessive HLA allele sharing may have impaired immunological tolerance of the conceptus. Also used in PGT-M + HLA programmes for saviour sibling selection (e.g. for stem cell donation to an affected sibling), and in haematopoietic stem cell transplant workup.

PatientsClinicians
Request Full Test List & Pricing →
Our Technology

Ion Torrent NGS — built for reproductive precision

We run PGT-A and NGS-based tests on the Thermo Fisher Ion Torrent semiconductor sequencing platform — delivering speed, accuracy, and scalability that conventional microarrays cannot match.

🔬

Ion Torrent Semiconductor Sequencing

Direct detection of nucleotide incorporation with no optical imaging required. Delivers rapid, cost-effective whole-genome copy number profiling at clinical-grade quality for reproductive genetics applications.

🧮

Whole-Chromosome Copy Number Analysis

Simultaneous screening of all 24 chromosomes (22 autosomes + X + Y) in a single run. Identifies full aneuploidies and segmental imbalances across the entire genome — no targeted probes, no coverage gaps.

📈

Mosaicism Detection & Reporting

Quantitative NGS read-depth analysis enables classification and reporting of mosaic embryos with percentage estimates, following current PGDIS/ESHRE guidelines for clinical decision-making support.

🧪

Trophectoderm Biopsy Compatible

Workflow optimised for Day 5/6 trophectoderm biopsy at the blastocyst stage. Also compatible with Day 3 cleavage-stage biopsy and single-cell samples where clinically required.

💊

PGT-M Gene Sequencing

Targeted sequencing of disease-causing variants combined with haplotype-based linkage analysis — enabling PGT-M for virtually any single-gene disorder with a known familial variant.

🪥

Cell-Free Fetal DNA Analysis (NIPT)

Maternal plasma cfDNA isolation and massively parallel sequencing for non-invasive prenatal detection of common trisomies and sex chromosome aneuploidies with >99% sensitivity and specificity.

NGS vs Arrays

Why sequencing-based PGT-A outperforms arrays

✓ NGS (Ion Torrent) — What We Use

  • Detects whole-chromosome and segmental aneuploidies
  • Quantitative mosaicism detection and percentage reporting
  • Higher resolution for small segmental imbalances
  • Scalable — any number of embryos per batch run
  • No pre-designed probe panels or coverage gaps
  • Adopted as the standard in leading international PGT centres

Array-Based PGT-A — Older Technology

  • Limited resolution for segmental changes
  • Lower sensitivity for mosaicism
  • Fixed probe coverage with gaps in detection
  • Higher cost per sample at scale
  • Less quantitative data output per run
  • Being phased out at major international PGT centres
For Patients

Understanding genetic testing — without the jargon

We know that fertility treatment is emotionally and medically overwhelming. This guide explains everything you need to know about genetic testing during your IVF journey — in plain, compassionate language.

What Is Genetic Testing?

Why genetics matters in IVF

The single biggest reason IVF cycles fail or result in miscarriage is that the embryo has an abnormal number of chromosomes — a condition called aneuploidy. In fact, more than 50% of all human embryos are chromosomally abnormal, and this proportion increases significantly with the mother's age.

Genetic testing allows us to examine the chromosomes inside your embryos before transfer, so your doctor can select only healthy, chromosomally normal (euploid) embryos. This dramatically improves your chances of a successful pregnancy and healthy baby.

At Tattvagene, we use Next Generation Sequencing (NGS) on the Thermo Fisher Ion Torrent platform — the most advanced and accurate technology available for embryo testing — to analyse all 24 chromosomes simultaneously.

Did you know?

Over 50% of early miscarriages are caused by chromosomal abnormalities in the embryo — not by anything the mother did or didn't do.

The age factor

At age 35, around 40% of embryos are chromosomally abnormal. By age 40, this rises to over 70%. PGT-A helps identify the healthy ones.

Safe for the embryo

Trophectoderm biopsy removes just 5–10 cells from the part of the embryo that becomes the placenta — not the baby. Thousands of healthy babies have been born after this procedure worldwide.

Your Journey

What to expect — step by step

Here is exactly what happens from the moment your doctor recommends genetic testing to the day of your embryo transfer.

01

Your doctor recommends genetic testing

Your IVF specialist will discuss whether genetic testing is appropriate for your specific situation. This is usually recommended if you are 35 or older, have had previous failed IVF cycles, have experienced recurrent miscarriage, have a known genetic condition in the family, or have a partner with a chromosomal abnormality. There is no obligation — your doctor will help you make an informed decision.

02

Your IVF cycle proceeds normally

You undergo your normal IVF stimulation cycle — hormone injections to grow multiple eggs, followed by egg collection under sedation. The eggs are fertilised in the laboratory, and the resulting embryos are grown to Day 5 or Day 6 (the blastocyst stage). This part of the process is identical to a standard IVF cycle.

03

Embryo biopsy — quick, safe, and painless

On Day 5 or 6, your embryologist carefully removes 5–10 cells from the outer layer (trophectoderm) of each blastocyst embryo. This layer becomes the placenta — not the baby — so this procedure does not harm the embryo. You will not feel anything as this happens in the laboratory. Each embryo is given a unique ID so results can be matched exactly. After biopsy, your embryos are vitrified (frozen) at ultra-low temperature and safely stored until your transfer cycle.

04

Genetic analysis at Tattvagene

The biopsy samples are carefully transported to our laboratory in Koramangala, Bengaluru. Our scientists analyse the DNA from each sample using the Ion Torrent NGS platform, examining all 24 chromosomes (chromosomes 1–22, X and Y) in a single test. We look for extra or missing chromosomes (aneuploidy), as well as mosaic findings (where some cells are normal and some are not). Results are typically ready within a few working days.

05

Understanding your results

Your doctor receives a detailed report for each embryo, classifying it as euploid (chromosomally normal — highest chance of a healthy pregnancy), aneuploid (chromosomally abnormal — not suitable for transfer), or mosaic (a mixture of normal and abnormal cells — your doctor will discuss the implications). Your doctor will explain the results and help you decide which embryo to transfer first.

06

Frozen embryo transfer

In the following cycle, your uterine lining is prepared with hormones, and your best euploid embryo is thawed and transferred. This is a simple, painless procedure similar to a smear test. Because the embryo has been selected based on its chromosomal status, your chance of successful implantation is significantly higher than in an untested cycle. If you have multiple euploid embryos, the remaining ones stay frozen safely for future attempts.

Tests Explained

Which test is right for you?

Tattvagene offers several different genetic tests. Your doctor will advise which is most appropriate, but here is a plain-language guide to each.

PREIMPLANTATION

PGT-A — Chromosome Screening

What it is

PGT-A (Preimplantation Genetic Testing for Aneuploidies) screens the chromosomes of your IVF embryos before transfer. Using our Ion Torrent NGS platform, we check all 24 chromosomes in every embryo to identify which ones have the correct number of chromosomes.

Who it is for

  • Women aged 35 and above
  • Two or more failed IVF cycles
  • Recurrent miscarriage (2+ losses)
  • Previous chromosomally abnormal pregnancy
  • Severe male factor infertility
  • Couples wanting to maximise IVF success
PREIMPLANTATION

PGT-M — Monogenic (Single Gene) Disorder Testing

What it is

PGT-M tests embryos for a specific inherited condition that runs in your family — caused by a mutation in a single gene. If you or your partner carry a known genetic mutation, PGT-M identifies which embryos have inherited it, allowing only unaffected embryos to be transferred. A pre-test workup (4–8 weeks) is required before your IVF cycle to design a test specific to your family's mutation.

Conditions we test for

  • Beta-Thalassemia
  • Duchenne Muscular Dystrophy (DMD)
  • Osteogenesis Imperfecta
  • Glycogen Storage Disorders
  • Spinal Muscular Atrophy (SMA)
  • Any known familial single-gene condition
PREIMPLANTATION

PGT-SR — Structural Rearrangement Testing

What it is

Some individuals carry a balanced chromosomal rearrangement — where sections of chromosomes have swapped positions. The carrier is unaffected, but their embryos are at high risk of having an unbalanced amount of chromosomal material, which causes miscarriage or a serious chromosomal condition. PGT-SR identifies embryos with a balanced or normal chromosomal arrangement that are safe to transfer.

Who it is for

  • One partner has a balanced translocation
  • One partner has a chromosomal inversion
  • History of recurrent miscarriage with no other cause
  • Previous child with an unbalanced chromosome abnormality
PRENATAL

NIPT — Non-Invasive Prenatal Testing

What it is

NIPT is a simple blood test performed from 10 weeks of pregnancy. Small fragments of your baby's DNA circulate in your blood during pregnancy. We isolate and analyse this cell-free fetal DNA to check for common chromosomal conditions. It is non-invasive — meaning no needles near the baby and no risk to the pregnancy whatsoever. It has a detection rate of over 99% for the conditions it screens for.

What it screens for

  • Trisomy 21 — Down syndrome (extra chromosome 21)
  • Trisomy 18 — Edwards syndrome (extra chromosome 18)
  • Trisomy 13 — Patau syndrome (extra chromosome 13)
  • Sex chromosome conditions (Turner, Klinefelter, etc.)
  • Optional: fetal sex determination
CYTOGENETICS

Karyotyping & FISH

What they are

Karyotyping is a standard chromosome analysis from a blood sample. It produces a visual map of all 46 chromosomes and can detect large-scale abnormalities in number or structure. FISH (Fluorescence In Situ Hybridisation) uses fluorescent probes to detect specific chromosomal abnormalities rapidly and precisely — for example microdeletion syndromes or sperm chromosome analysis.

Who should consider these

  • Couples with unexplained infertility
  • Men with azoospermia or very low sperm count
  • Women with premature ovarian insufficiency
  • Couples with recurrent miscarriage
  • Family history of chromosomal conditions
  • Prenatal diagnosis (amniocentesis / CVS samples)
Common Concerns

Questions we hear most often

Will genetic testing guarantee a pregnancy?

No test can guarantee a pregnancy. However, PGT-A significantly improves your chances per transfer by ensuring only chromosomally normal embryos are transferred. It reduces wasted cycles on embryos that would not have implanted or would have miscarried.

What if all my embryos are abnormal?

This is hard news to receive. However, knowing this early means you can pursue another stimulation cycle rather than going through failed transfers. Your fertility doctor will discuss all options including a further cycle, donor eggs, or adoption.

What does mosaic mean for my embryo?

A mosaic embryo has a mixture of chromosomally normal and abnormal cells. Some mosaic embryos have been transferred successfully and resulted in healthy babies. The decision to transfer a mosaic embryo is a clinical one — your doctor and our team will explain what the specific findings mean for your embryo and help you decide.

Is the biopsy painful?

The biopsy is performed on the embryo in the laboratory — you will not be present and will feel nothing. It is a very precise procedure performed by skilled embryologists under a microscope and does not involve any procedure on you.

How long will the whole process take?

After your embryo biopsy, results are typically available within a few working days. Your embryo transfer then happens in the following cycle — usually 4–6 weeks after biopsy. For PGT-M, an additional 4–8 week pre-test workup is needed before your IVF cycle begins.

Can I do genetic testing if I'm already pregnant?

Yes — NIPT is a prenatal test done from 10 weeks of an existing pregnancy. It screens for chromosomal conditions using a simple blood draw and carries no risk to the baby. If you are pregnant and concerned, please contact us or speak to your obstetrician.

Ready to take the next step?

Our team is here to answer every question, no matter how big or small. Reach out today and we will help you understand your options.

For Clinicians

Your dedicated reproductive genetics partner

We work alongside IVF clinics and fertility specialists across India — providing rigorous NGS-based genetic testing, streamlined referral coordination, and expert clinical support for every case.

Call: +91 80 4172 2600
Why Partner With Us

What we offer your practice

🧬

Ion Torrent NGS Platform

We run PGT-A on the Thermo Fisher Ion Torrent semiconductor sequencing platform — delivering whole-genome copy number analysis across all 24 chromosomes with quantitative mosaicism detection. NGS outperforms arrays in resolution, sensitivity, and clinical utility.

📋

Detailed, Actionable Reports

Each PGT-A report includes chromosomal status for all 24 chromosomes per embryo, quantified mosaic calls with percentage estimates, segmental imbalance reporting, and clinical guidance notes. Reporting follows current PGDIS/ESHRE international guidelines.

Cycle-Friendly Turnaround

Our TAT is designed specifically around freeze-all protocols and frozen embryo transfer cycles. Results are delivered within a few working days of sample receipt. For time-sensitive cases, expedited reporting is available — contact us to discuss.

🤝

Open Referral — All Clinics Welcome

We accept referrals from all IVF clinics and fertility specialists regardless of affiliation, size, or location. Our services are available to the entire fertility community across Karnataka and beyond.

💬

Scientific Director Support

Our scientific directors — Dr. Jayarama S. Kadandale and Dr. Swathi Shetty — are available for pre-test consultation on complex cases, post-report clinical discussion, and support for mosaic embryo transfer decisions. We speak your clinical language.

🔬

10 Years & 5000+ Cases

Founded in 2015, Tattvagene is one of India's most experienced reproductive genetics laboratories. With over 5000 PGT-A cases performed, our clinical knowledge and quality assurance systems are proven at scale.

Our Services in Detail

What we offer for your patients

PGT-A

Preimplantation Genetic Testing for Aneuploidies

Platform & Method

Thermo Fisher Ion Torrent semiconductor NGS. Whole-genome copy number analysis across all 24 chromosomes (22 autosomes + X + Y) per embryo per run. Quantitative read-depth method enables both full aneuploidy calling and mosaic detection with percentage estimation.

What We Report

  • Full chromosomal status all 24 chromosomes
  • Whole-chromosome aneuploidies
  • Segmental aneuploidies (>10 Mb)
  • Mosaic findings with % quantification
  • PGDIS/ESHRE classification per embryo
  • Amplification QC metrics

Indications

  • Advanced maternal age (≥35)
  • Recurrent implantation failure
  • Recurrent pregnancy loss
  • Severe male factor
  • Previous aneuploid pregnancy
  • Unexplained infertility
PGT-M

Preimplantation Genetic Testing for Monogenic Disorders

Method

Family-specific assay design using haplotype-based linkage analysis combined with direct mutation detection. A pre-test workup of 4–8 weeks is required per new condition before the IVF cycle. Proband and/or carrier samples are needed for assay design.

Conditions We Test

  • Beta-Thalassemia
  • Duchenne Muscular Dystrophy
  • Osteogenesis Imperfecta
  • Glycogen Storage Disorders
  • Spinal Muscular Atrophy
  • Any known familial variant

Special Programmes

Saviour sibling programmes (PGT-M + HLA matching) available for couples seeking a histocompatible donor sibling for an affected child. Contact our scientific directors to discuss feasibility for complex or rare conditions.

PGT-SR

Preimplantation Genetic Testing for Structural Rearrangements

Method & Coverage

NGS-based whole-genome copy number profiling identifies unbalanced chromosomal rearrangements in embryos from carriers of reciprocal translocations, Robertsonian translocations, and chromosomal inversions. Results identify embryos with a balanced or normal chromosomal complement suitable for transfer.

Indications

  • Known reciprocal or Robertsonian translocation carrier
  • Chromosomal inversion (pericentric or paracentric)
  • Recurrent miscarriage with known rearrangement
  • Previous child with unbalanced rearrangement
NIPT

Non-Invasive Prenatal Screening

cfDNA-based screening from 10 weeks gestation. >99% detection rate for Trisomies 21, 18, 13 and sex chromosome aneuploidies. Suitable for singleton and twin pregnancies including IVF conceptions. Maternal plasma collected in Streck tubes; 10 mL required.

Report time: typically within 5 working days of sample receipt.

CYTOGENETICS

Karyotyping, FISH & HLA Typing

G-banded karyotyping from peripheral blood (lithium heparin) or prenatal samples (amniocentesis/CVS). FISH panels for microdeletion syndromes, SRY verification, and sperm FISH. HLA typing for RIF/RPL workup and PGT-M + HLA (saviour sibling) programmes.

Contact us for specific sample requirements and turnaround times.

Referral Process

How to work with us

We have designed our referral and coordination process to be as frictionless as possible for busy fertility clinics. Here is how it works, step by step.

1

Initial contact & case discussion

Call or email us with the patient's clinical background — indication for testing, number of embryos expected, any known genetic conditions in the family, and the test required. Our scientific directors are available to discuss complex or unusual cases before you formally refer. For PGT-M, this initial consultation is essential to assess feasibility and plan the pre-test workup timeline.

2

Documentation & consent

We provide test-specific request forms, patient consent forms (in English and Kannada), and sample collection guidelines. For PGT-A, biopsy collection protocol and transport guidelines are provided to your embryology lab. For PGT-M, additional family history forms and requirements for proband/carrier blood samples will be issued.

3

Sample collection & biopsy coordination

For PGT-A and PGT-SR: trophectoderm biopsy is performed by your embryologist on Day 5 or 6 blastocysts. Biopsy cells are collected in labelled 0.2 mL PCR tubes with minimal PBS. Embryos are vitrified immediately post-biopsy. Samples are transported to our laboratory fresh on dry ice or as pre-vitrified biopsy cells — we coordinate logistics with your embryology team to ensure optimal handling and chain-of-custody documentation.

4

Analysis & quality control

On receipt, samples undergo whole genome amplification (WGA) followed by NGS library preparation and sequencing on our Ion Torrent platform. Internal QC metrics (amplification efficiency, sequencing coverage, noise levels) are checked at each stage. Samples that fail QC are flagged immediately and re-analysis options discussed with you before final reporting.

5

Report delivery

Reports are delivered securely to the referring clinician via email in PDF format. Each PGT-A report includes: a summary table of all embryos with chromosomal classification, detailed chromosome plots per embryo, mosaic findings with % estimates per affected chromosome, a clinical notes section, and the reporting scientist's signature. Reports follow the PGDIS/ESHRE international classification criteria.

6

Post-report support

Our scientific directors are available for clinician-to-clinician discussion on complex findings — particularly mosaic embryo transfer decisions, segmental imbalance interpretation, and PGT-M result counselling. We can also provide written case summaries for complex cases on request. Patient-facing genetic counselling support can be arranged through our team where needed.

Sample Requirements

Biopsy & sample handling guidelines

Trophectoderm Biopsy (PGT-A / PGT-SR)

  • Stage:Day 5 or Day 6 blastocyst (preferred)
  • Cell number:5–10 trophectoderm cells per biopsy
  • Tube:0.2 mL PCR tube, individually labelled per embryo
  • Buffer:Minimal Ca/Mg-free PBS (1–2 µL maximum)
  • Post-biopsy:Embryo vitrified immediately; biopsy tube snap-frozen on dry ice
  • Transport:Fresh on dry ice within 24 hours, or as vitrified biopsy cells
  • Chain of custody:Full documentation required; unique patient and embryo IDs

Day 3 Cleavage Biopsy (where indicated)

  • Stage:Day 3 cleavage stage (8-cell stage ideal)
  • Cell number:Single blastomere per embryo
  • Note:Higher allele dropout risk vs trophectoderm biopsy; discuss on a case-by-case basis with our team
  • QC:Full amplification QC reported alongside results; ADO rate stated per sample
  • Recommendation:Contact our scientific directors before proceeding with Day 3 biopsy for advice on your specific case

Maternal Blood for NIPT

  • Volume:10 mL maternal peripheral blood
  • Tube:Streck cell-free DNA BCT tubes (or equivalent cfDNA preservation tube)
  • Gestation:Minimum 10+0 weeks; maximum 22 weeks
  • Conception:Singleton and twin pregnancies; IVF and natural conceptions accepted
  • Transport:Room temperature; process within 5 days of collection
  • Please note:Gestational age and conception method must be stated on request form

Blood Samples (Karyotyping / FISH / HLA)

  • Karyotyping:5–10 mL peripheral blood in lithium heparin tube
  • FISH:3–5 mL peripheral blood in lithium heparin; or specific prenatal sample as agreed
  • HLA Typing:5 mL EDTA blood
  • Sperm FISH:Neat semen sample or washed sperm prep as per our protocol — contact us for specifics
  • Prenatal samples:Amniotic fluid or CVS accepted — prior coordination required; contact us before collection
📋

Request full sample guidelines

Contact us to receive our complete sample collection and transport guidelines document, including request forms, consent templates, and chain-of-custody forms tailored for your laboratory.

Ready to refer a patient?

Our team is ready to assist — from initial case discussion through to report interpretation. Get in touch today.

Call: +91 80 4172 2600 tattvagene@gmail.com
Our Team

The people behind Tattvagene

Our laboratory is led by specialist geneticists and supported by a dedicated team of clinical laboratory scientists with deep expertise across cytogenetics and molecular genetics.

Dr. Jayarama S. Kadandale
J

Dr. Jayarama S. Kadandale

Scientific Director
M.Sc., PhD

PhD from University of Mysore; trained at Indian Institute of Science, Bangalore; University of Tennessee Health Science Centre, Memphis; and Memorial Sloan Kettering Cancer Centre, NY. Licensed Specialist in Clinical & Molecular Cytogenetics (Tennessee, USA). Over 25 years of experience in clinical and molecular cytogenetic investigations for prenatal, neonatal, microdeletion, fertility, and cancer diagnostics.

Dr. Swathi Shetty
S

Dr. Swathi Shetty

Scientific Director
M.Sc., PhD

PhD in Genetics from La Trobe University, Australia. Over 18 years of experience in molecular genetic research and diagnostics. Instrumental in establishing Molecular Diagnostics (DNA diagnostics), Prenatal Genetic Diagnostics, and NGS-based testing in both research and clinical diagnostic settings.

Mr. Sachin Shetty
S

Mr. Sachin Shetty

Researcher
BE (Biotechnology)

BE in Biotechnology from PA College of Engineering, Mangalore (VTU). Worked at Centre for Human Genetics, Bangalore (2014–2015). Joined Tattvagene in 2015 as Clinical Laboratory Scientist – Molecular. Extensive expertise in NGS technology, HLA sequence analysis, and prenatal and postnatal techniques.

Mrs. Jnapti Johnson
J

Mrs. Jnapti Johnson

Researcher
BE (Biotechnology), MBA

BE in Biotechnology from New Horizon College of Engineering, Bangalore (VTU) and MBA in International Business from Annamalai University. Worked at Centre for Human Genetics (2013–2015). Joined Tattvagene in 2015 as Clinical Laboratory Scientist – Cytogenetics.

Ms. Ashly Santhosh
A

Ms. Ashly Santhosh

Researcher
M.Sc. (Genetics)

M.Sc. in Genetics from University of Mysore. Research Assistant at Centre for Human Genetics, Bangalore (2019–2021). Currently working as Scientific Assistant in the molecular department at Tattvagene.

Ms. Sowmya Joshi
S

Ms. Sowmya Joshi

Researcher
M.Sc. (Applied Genetics)

Master's in Applied Genetics. Currently working as Scientific Assistant Trainee in the cytogenetics department at Tattvagene. Previously worked as a freelance academic editor.

Work With Us

Consult our scientific directors

Whether you have a complex clinical case or would like to discuss the right test for your patient, our scientific directors are available for consultation.

Contact Us →
Frequently Asked Questions

Answers for patients & clinicians

Patient Questions Patients

What is PGT-A and why is it recommended?+
PGT-A screens IVF embryos for chromosome number abnormalities before transfer to the uterus. Most miscarriages and failed IVF cycles are caused by chromosomally abnormal embryos. By transferring only euploid (chromosomally normal) embryos, PGT-A significantly improves pregnancy rates and reduces miscarriage risk.
Does embryo biopsy harm the embryo?+
No. Trophectoderm biopsy at Day 5/6 removes just 5–10 cells from the outer layer that will form the placenta — not the cells that form the baby. Decades of worldwide data confirm the safety of this procedure. The embryo is vitrified immediately after biopsy and stored until the transfer cycle.
How long does it take to get results?+
Our PGT-A turnaround is designed to fit IVF cycle timelines. Results are typically available within a few working days of receiving the biopsy sample — compatible with embryo vitrification and frozen embryo transfer in the following cycle.
What is NIPT and when should I do it?+
NIPT is a blood test done from 10 weeks of pregnancy. It analyses fragments of your baby's DNA in your blood to check for Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), and sex chromosome conditions. It carries no risk to the pregnancy and has a detection rate over 99%.
What is a mosaic embryo? Should I transfer it?+
A mosaic embryo has a mixture of chromosomally normal and abnormal cells. Clinical significance depends on which chromosome is involved and the proportion of abnormal cells. Our reports include quantified mosaic classification, and our scientific directors can discuss the implications with your fertility doctor to support the transfer decision.
Is PGT-M available for rare conditions?+
PGT-M requires a pre-test workup where we design a family-specific assay. We have experience with Beta-Thalassemia, Duchenne Muscular Dystrophy, Osteogenesis Imperfecta, Glycogen Storage Disorders, and other rare conditions. Please contact us to discuss feasibility and timelines for your specific situation.
What does a euploid embryo result mean?+
A euploid embryo has the correct number of chromosomes — 23 pairs, 46 total. These embryos have the highest chance of implanting and resulting in a healthy pregnancy. PGT-A allows your doctor to select euploid embryos for transfer, avoiding cycles wasted on embryos that would fail to implant or miscarry.

Clinician Questions Clinicians

What NGS platform does Tattvagene use for PGT-A?+
We use the Thermo Fisher Ion Torrent semiconductor sequencing platform. This enables whole-chromosome copy number analysis across all 24 chromosomes in a single run, with quantitative detection of aneuploidy, segmental imbalances, and mosaicism.
How should embryo biopsy samples be sent?+
Biopsy cells are collected in 0.2 mL PCR tubes with minimal PBS (as per your lab's protocol). Samples can be sent fresh on dry ice or as previously vitrified biopsies. Our team will provide detailed handling instructions and coordinate with your embryology lab to ensure sample integrity throughout transit.
What does your mosaicism reporting include?+
Our PGT-A reports include quantified mosaicism levels per chromosome, classified using current PGDIS/ESHRE guidelines. We report full aneuploidy, segmental aneuploidies, and mosaic findings with percentage estimates, providing the data you need for mosaic embryo transfer counselling.
What is the turnaround time for PGT-A?+
Our standard PGT-A TAT is designed for frozen embryo transfer cycles — reports are typically available within a few working days from sample receipt. We accommodate specific cycle requirements including expedited reporting. Please contact us to discuss your clinic's needs.
Can you handle PGT-M for a new, untested condition?+
Yes, with pre-test workup. For a new condition, we require proband/carrier samples for variant confirmation and family-specific assay design, typically taking 4–8 weeks before the IVF cycle begins. Our scientific directors provide expert guidance on complex cases.
Do you offer genetic counselling support?+
Yes. Our scientific directors are available for pre-test consultation and post-result discussion for complex cases — PGT-M assay design, mosaic embryo transfer decisions, and PGT-SR interpretation. We support clinician-to-clinician calls for patient management guidance.
Do you accept referrals from all fertility clinics?+
Absolutely. We welcome referrals from all IVF clinics and fertility specialists regardless of affiliation or location across India. Our referral process is straightforward — contact us to initiate and we will guide you through sample requirements and logistics.
Contact Us

Get in touch with our team

Whether you are a patient seeking information about genetic testing or a fertility specialist looking to refer a patient, we are here to help. We will respond promptly.

📍

Address

#365, Sulochana Building, 1st Cross Road, 3rd Block
Sarjapur Main Road, Koramangala, Bengaluru — 560 034

🕐

Working Hours

Monday – Saturday: 9:00 AM – 6:00 PM
Sunday: By appointment

Send us a message

Your information is kept strictly confidential and will only be used to respond to your enquiry.